Skip to content

A clinical trial to study the efficacy of two tests, SOFA score plus procalcitonin and SOFA score alone, in patients with sepsis

Comparison of SOFA score and serum procalcitonin combination with SOFA score alone in predicting short-term mortality in patients with sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036902
Enrollment
160
Registered
2021-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

ABVIMS and Dr RML hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than equal to 18 years Patients with diagnosis of Sepsis and or Septic shock Patients with ICU stay of at least 24 hours

Exclusion criteria

Exclusion criteria: Refusal of Consent Pregnant and lactating females Patients who later turn out to be non sepsis Acute non infectious inflammatory conditions like burns, acute pancreatitis, massive trauma Patients with chronic kidney disease Stage IV and V Patients on immunosuppressive medications Patients with terminal cancer Patients with thyroid cancer any stage

Design outcomes

Primary

MeasureTime frame
Short term mortality or 28 day mortality in patients with sepsisTimepoint: From admission into ICU till 28th day thereafter

Secondary

MeasureTime frame
Microbial culture result Duration of mechanical ventilation and or non-invasive ventilation Usage of inotropes or vasopressors Need for renal replacement therapy Length of ICU stayTimepoint: From admission into ICU till 28th day thereafter

Countries

India

Contacts

Public ContactProf Ranvinder Kaur

ABVIMS and Dr RML hospital

rsindhoo@yahoo.co.in9717932744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026